Aug. 12, 2020 Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and...

August 10, 2020 – LogicBio’s First IND Clearance Leveraging GeneRide, an In Vivo Homologous Recombination-based Genome Editing Platform –...

August 13, 2020 – Expect to initiate Phase 1a clinical study of BX002 for the treatment of IBD in the third quarter of 2020;...